<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Tuberc Respir Dis (Seoul)</journal-id><journal-id journal-id-type="iso-abbrev">Tuberc Respir Dis (Seoul)</journal-id><journal-id journal-id-type="publisher-id">TRD</journal-id><journal-title-group><journal-title>Tuberculosis and Respiratory Diseases</journal-title></journal-title-group><issn pub-type="ppub">1738-3536</issn><issn pub-type="epub">2005-6184</issn><publisher><publisher-name>The Korean Academy of Tuberculosis and Respiratory Diseases</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6435930</article-id><article-id pub-id-type="doi">10.4046/trd.2018.0009</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject><subj-group subj-group-type="subheading"><subject>Tuberculosis</subject></subj-group></subj-group></article-categories><title-group><article-title>Pre-immigration Screening for Tuberculosis in South Korea: A Comparison of Smear- and Culture-Based Protocols</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9175-9300</contrib-id><name><surname>Lee</surname><given-names>Sangyoon</given-names></name><degrees>M.D.</degrees><degrees>Ph.D.</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ryu</surname><given-names>Ji Young</given-names></name><degrees>M.D.</degrees><degrees>M.Sc.</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0521-3561</contrib-id><name><surname>Kim</surname><given-names>Dae-Hwan</given-names></name><degrees>M.D.</degrees><degrees>Ph.D.</degrees><xref ref-type="aff" rid="A2">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Occupational and Environmental Medicine, Inha University Hospital, Incheon, <country>Korea</country>.</aff><aff id="A2"><label>2</label>Department of Occupational and Environmental Medicine, Inje University Haeundae Paik Hospital, Busan, <country>Korea</country>.</aff><author-notes><corresp>Address for correspondence: Dae-Hwan Kim, M.D., Ph.D. Department of Occupational and Environmental Medicine, Inje University Haeundae Paik Hospital, 875 Haeun-daero, Haeundae-gu, Busan 48108, Korea. Phone: 82-51-797-0369, Fax: 82-51-797-0313, <email>kimdh@paik.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>28</day><month>9</month><year>2018</year></pub-date><volume>82</volume><issue>2</issue><fpage>151</fpage><lpage>157</lpage><history><date date-type="received"><day>16</day><month>1</month><year>2018</year></date><date date-type="rev-recd"><day>05</day><month>4</month><year>2018</year></date><date date-type="accepted"><day>02</day><month>7</month><year>2018</year></date></history><permissions><copyright-statement>Copyright&#x000a9;2019. The Korean Academy of Tuberculosis and Respiratory Diseases</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>The Korean Academy of Tuberculosis and Respiratory Diseases</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>It is identical to the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>)</license-p></license></permissions><abstract><sec><title>Background</title><p>Tuberculosis (TB) is the most important disease screened for upon patient history review during preimmigration medical examinations as performed in South Korea in prospective immigrants to certain Western countries. In 2007, the U.S. Centers for Disease Control and Prevention (CDC) changed the TB screening protocol from a smear-based test to the complete Culture and Directly Observed Therapy Tuberculosis Technical Instructions (CDOT TB TI) for reducing the incidence of TB in foreign-born immigrants.</p></sec><sec><title>Methods</title><p>This study evaluated the effect of the revised (as compared with the old) protocol in South Korea.</p></sec><sec><title>Results</title><p>Of the 40,558 visa applicants, 365 exhibited chest radiographic results suggestive of active or inactive TB, and 351 underwent sputum tests (acid-fast bacilli smear and <italic>Mycobacterium tuberculosis</italic> culture). To this end, using the CDOT TB TI, 36 subjects (88.8 per 10<sup>5</sup> of the population) were found to have TB, compared with only seven using the older U.S. CDC technical instruction (TI) (p&#x0003c;0.001). In addition, there were six drug-resistant cases which were identified (16.7 per 10<sup>5</sup> of the population), two of whom had multidrug-resistance (5.6 per 10<sup>5</sup> of the population).</p></sec><sec><title>Conclusion</title><p>The culture-based 2007 TI identified a great deal of TB cases current to the individuals tested, as compared to older U.S. CDC TI.</p></sec></abstract><kwd-group><kwd>Tuberculosis</kwd><kwd>Immigrants</kwd><kwd>Screening</kwd><kwd>Republic of Korea</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Some countries, including the United States, Canada, and Australia, require that prospective visitors seeking immigration, marriage, study, employment, working-holiday, or other visas must undergo a medical examination in a designated hospital. Identification of active tuberculosis (TB) cases is vital because the incidence thereof is much higher in South Korea (86.0 per 10<sup>5</sup> of the population) than in the United States (3.1 per 10<sup>5</sup> of the population), Canada (5.2 per 10<sup>5</sup> of the population), and Australia (6.4 per 10<sup>5</sup> of the population) in 2014<xref rid="B1" ref-type="bibr">1</xref>.</p><p>In 1991, the U.S. Centers for Disease Control and Prevention (CDC) drafted a technical instruction (TI) for TB screening and treatment of visa applicants; this TI featured chest radiography (CXR) and three consecutive acid-fast bacilli (AFB) smear tests on sputum if the CXR results were suggestive of TB. Although since 1991, the U.S. CDC TI for overseas TB screening has stipulated three consecutive AFB smear tests after an abnormal CXR, transmission of TB from AFB smear-negative patients remains important because of the relatively low predictive value of these tests. In 2007, the U.S. CDC expanded the TI to include three consecutive <italic>Mycobacterium tuberculosis</italic> (MTB) cultures of sputum in addition to the smear tests and mandated drug susceptibility testing (DST) and directly observed therapy (DOT) for those undergoing TB treatment (Culture and Directly Observed Therapy [CDOT] TB TI). Although some differences in the age of the subjects exist, the visa programs of many countries, including Canada, Australia, New Zealand, and the United States, follow the revised TI of the U.S. CDC.</p><p>The prevalence of smear- and/or culture-positive TB has diminished noticeably according to the nationwide Korean TB surveys that were conducted every 5 years from 1965 (940 per 10<sup>5</sup> of the population) to 1995 (219 per 10<sup>5</sup> of the population)<xref rid="B2" ref-type="bibr">2</xref>. The Korean Tuberculosis Surveillance System (KTBS), an internet-based system of case notification, was adopted in 2000, but this system has been criticized. Notification of TB cases, especially by private institutions, may be neglected or incomplete, which could lead to an underestimation of the TB burden<xref rid="B3" ref-type="bibr">3</xref>.</p><p>We compared the incidence of TB among visa applicants screened using the culture-based protocol with that determined using the smear-based protocol. Additionally, we indirectly estimated the status of TB in South Korea from the number of cases of active TB identified in medical screening examinations of visa applicants.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>1. Subjects and study design</title><p>A total of 43,488 visa applicants underwent medical examinations in a private general hospital in Busan from May 1, 2011, to July 31, 2015 at the request of the embassies of the United States, Canada, and Australia. Prior to 2007, overseas TB screening of pre-immigrants 15 or more years of age before departure for the U.S. comprised CXR. If the CXR results were abnormal, which is suggestive of active TB, three consecutive AFB smear tests were performed on sputum. If any of the tests were positive, the subject was considered to have class A TB. If all smear tests were negative, the subject was classified with class B1 TB (<xref ref-type="fig" rid="F1">Figure 1</xref>). The TI was expanded in 2007; three consecutive AFB sputum tests are still required, in addition to MTB culture tests if the CXR results are abnormal, in subjects with evident signs or symptoms of TB on medical examination, any history of TB, or human immunodeficiency virus infection. If any of the sputum or culture tests are positive, the subject is considered to have class A TB. If all smear and culture tests are negative, the subjected is classified with class B1 TB. Class A patients then undergo DST and DOT<xref rid="B4" ref-type="bibr">4</xref> (<xref ref-type="fig" rid="F2">Figure 2</xref>). We retrospectively compared the number of class A TB patients among visa applicants using the (enhanced) 2007 TI and the 1991 TI.</p></sec><sec><title>2. Laboratory examinations</title><p>The laboratory examination followed the TB diagnostic standards of the U.S. CDC and the American Thoracic Society<xref rid="B5" ref-type="bibr">5</xref>. Three consecutive AFB smear tests on sputum and three MTB cultures were performed on three successive days; the examiner donned protective gloves and a N95 mask when collecting sputum. The room in which sputum was collected was under negative pressure and was fitted with a ultraviolet-based sterilizing system<xref rid="B6" ref-type="bibr">6</xref>. If sputum production was difficult, sputum was induced by inhalation of an aerosol consisting of sterile hypertonic saline. Sputum specimens were stained using the Ziehl-Neelsen method and cultured on both solid medium (3% egg-based Ogawa medium) and in liquid medium (Middlebrook 7H12 medium); subjects with a single positive result on AFB smear or culture tests were considered TB positive. Detection of non-TB mycobacteria (NTM) was not considered a positive result. DST was performed using the absolute concentration method in Lowenstein-Jensen medium. Pyrazinamide susceptibility testing was performed by the pyrazinamidase test. If a culture test was positive, DST was performed for amikacin, capreomycin, cycloserine, ethambutol, isonazid, kanamycin, levofloxacin, moxifloxacin, ofloxacin, para-aminosalicylic acid, prothionamide, pyrazinamide, rifabutin, rifampicin, and streptomycin. Multidrug-resistant (MDR) TB (MDR-TB) was defined as TB resistant to both isoniazid and rifampicin, while extensive drug-resistant TB (XDR-TB) was defined TB that was also resistant to any fluoroquinolone (ofloxacin, moxifloxacin, or levofloxacin) and at least one second-line injectable drug (amikacin, capreomycin, or kanamycin), as well as MDR<xref rid="B7" ref-type="bibr">7</xref>.</p></sec><sec><title>3. Statistical analysis</title><p>We documented the general characteristics of the population and calculated the rate of TB cases. The chi-square test and Fisher's exact test were used to compare proportions. Continuous variables are expressed as the mean&#x000b1;standard deviations (SDs) and categorical variables were expressed as numbers and percentages. All tests of significance were two-sided, and a p-value of &#x0003c;0.05 was deemed to reflect statistical significance. All analyses were performed using SAS software version 9.2 (SAS Institute Inc., Cary, NC, USA).</p></sec><sec><title>4. Ethics statement</title><p>An ethics review was performed, and permission to collect data from the visa applicants was obtained from the institutional review board of Haeundae Paik Hospital (IRB No. 2016-07-009-001). The requirement for informed consent was waived because this study involved only a review of the medical records and posed minimal risk to the subjects.</p></sec></sec><sec sec-type="results"><title>Results</title><p>Among the 43,488 applicants, we excluded those under 15 years of age (n=444) who did not take CXR according to the U.S. CDC protocol, as well as foreigners (n=592). Applicants who visited several times because of repeat visits to one country or visits to several countries (n=1,887) were counted only once. Finally, we evaluated 40,558 subjects. The average age (&#x000b1;SD) of the population was 26.8 (&#x000b1;6.6) years; 21,980 (54.2%) were aged 25&#x02013;34 years, 15,532 (38.3%) were 15&#x02013;24 years, with those of younger age (15&#x02013;34 years) constituting 90% of the population. Thirty-one applicants stated that they had previously undergone treatment for TB. Abnormal CXR results suggestive of either inactive or active TB were obtained from 365 subjects (0.9%, 899.9 per 10<sup>5</sup> of the population) (<xref rid="T1" ref-type="table">Table 1</xref>).</p><p>Fourteen subjects refused further sputum examinations, and 351 underwent three sputum AFB smear tests and MTB cultures. Seven subjects had at least one positive smear test and 33 at least one positive MTB culture. Twenty-nine subjects were negative on the AFB smear tests but positive on the culture tests. One positive sputum test was associated with a positive MTB culture in 11 cases, two sputum tests were associated with positive cultures in 17 cases, and all three sputum tests were positive in five cases, together with positive culture data (<xref rid="T2" ref-type="table">Table 2</xref>).</p><p>TB was identified in 36 subjects (88.8 per 105 of the population) using the CDOT TB TI but in only seven using the 1991 U.S. CDC TI (p&#x0003c;0.001). When evaluated by sex, 22 males (96.8 per 10<sup>5</sup> of the population) and 14 females (78.5 per 10<sup>5</sup> of the population) were classified with TB using the 2007 TI, but only four males and three females were classified with TB using the 1991 TI; these differences were statistically significant (p&#x0003c;0.001 and p=0.007, respectively). Six cases were resistant to at least one TB drug (16.7%), and two were MDR-TB (5.6%) according to the CDOT TB TI (<xref rid="T3" ref-type="table">Table 3</xref>).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>In total, 36 cases of TB were detected in visa applicants using the CDOT TB TI (88.8 per 10<sup>5</sup> of the population). The incidence was found to be already high in younger subjects (118.3 per 10<sup>5</sup> of the population aged 25&#x02013;34 years) and to increase with age. When the older smear-based U.S. CDC TI was used, only seven applicants were classified as having TB; thus, 29 positive TB cases (80.6%) were missed when the older TI was used.</p><p>The prevalence of TB in South Korea has decreased with an improving economy, but TB control remains unsatisfactory<xref rid="B8" ref-type="bibr">8</xref>. A public health problem is evident. The incidence of TB (86 per 10<sup>5</sup> of the population) is the highest among the 34 countries of the Organization for Economic Cooperation and Development (OECD) in 2014; the average TB incidence in the other 33 OECD countries was only 9.76 per 10<sup>5</sup> of the population in 2014<xref rid="B1" ref-type="bibr">1</xref>. In the United States from 2001 to 2008, South Koreans accounted for 8.1% of all estimated TB cases among newly arrived students/exchange visitors and for 6.2% of TB cases among newly arrived tourists and business travelers, ranking as the fourth and seventh most significant sources of infection, respectively<xref rid="B9" ref-type="bibr">9</xref>.</p><p>Immigration has been an important cause of TB in high-income countries. In the United States, for example, 64% of new TB cases in 2013 were attributable to infections spread from foreign-born subjects<xref rid="B10" ref-type="bibr">10</xref>. The U.S. CDC conducted a preliminary study on the effectiveness of pre-immigration TB screening programs in Vietnam among 1,179 U.S.-bound immigrants with abnormal CXRs; positive AFB smear results were detected in 82 (7.0%) immigrants, positive MTB culture results in 183 (15.5%), and negative smear but positive culture results in 120 (10.2%)<xref rid="B11" ref-type="bibr">11</xref>. Follow-up evaluation from 1999 to 2005 revealed that 7.0% of smear-negative TB immigrants were diagnosed with active TB after arrival in the United States<xref rid="B12" ref-type="bibr">12</xref>. A DNA fingerprinting study performed in the United States showed that at least 17% of TB patients had been infected by smear-negative patients; the relative TB transmission rate from smear-negative to smear-positive patients was found to be 0.22 (95% confidence interval, 0.16&#x02013;0.32)<xref rid="B13" ref-type="bibr">13</xref>.</p><p>The AFB smear test has a sensitivity of about 53%. A second specimen increases this to 64.4% and a third specimen increases this to 66.4%&#x02013;69.4%<xref rid="B14" ref-type="bibr">14</xref>. This is because 5,000&#x02013;10,000 AFB per microliter sputum sample are required for a positive result<xref rid="B15" ref-type="bibr">15</xref>, compared to 10&#x02013;100 AFB per microliter for a sputum culture<xref rid="B16" ref-type="bibr">16</xref>, which has a sensitivity of 80%&#x02013;85% and specificity of about 98%<xref rid="B17" ref-type="bibr">17</xref><xref rid="B18" ref-type="bibr">18</xref><xref rid="B19" ref-type="bibr">19</xref>. The low sensitivity of the AFB smear test is also attributable to differences in staining technique, centrifugation speed, reader experience, and the TB prevalence in the population (30%&#x02013;80%)<xref rid="B17" ref-type="bibr">17</xref><xref rid="B20" ref-type="bibr">20</xref>. In this study, the culture test identified 33 TB cases, compared to seven for the AFB smear test.</p><p>After implementation of culture-based TB screening in subjects from countries with a high TB burden in 2007, the annual number of TB cases diagnosed within 1 year of arrival among foreign-born subjects decreased steadily from 1,326 to 940 (2008&#x02013;2012) compared with the 1,424&#x02013;1,626 (mean 1,504) cases (2002&#x02013;2007) diagnosed prior to implementation of the new TI. Concomitantly, the incidence of smear-negative culture-positive cases increased from 178 (42.4%) in 2008 to 629 (59.5%) in 2012<xref rid="B21" ref-type="bibr">21</xref>. Approximately 60% of immigrants and refugees with TB had negative smear results but positive culture results, according to the U.S. CDC<xref rid="B22" ref-type="bibr">22</xref>. The enhanced screening program reduced the occurrence of TB within 6 months of arrival in the United States from 86 of 2,049 subjects (4.2%) (preintervention; applying the 1991 TI) to 22 of 1,430 subjects (1.5%) post-intervention (applying the new 2007 TI)<xref rid="B23" ref-type="bibr">23</xref>. In the present study, 29 of 36 cases (80.5%) were smear-negative but culture-positive using the 2007 TI, whereas only seven were diagnosed with TB using the 1991 TI.</p><p>Drug-resistant TB was not uncommon in this study. DST is included in the enhanced TI to identify drug-resistant TB cases and to treat MDR-TB. In a four-round Korean study on national drug resistance conducted from 1994 to 2004, the prevalence of anti-TB drug resistance increased steadily from 11.3% to 12.8% and that of MDR from 1.6% to 2.7% of new cases and 27.5% to 14.0% of previously treated cases, respectively<xref rid="B24" ref-type="bibr">24</xref>. In a previous Korean study, 5.8% of new cases and 20.1% of previously treated cases had MDR-TB<xref rid="B25" ref-type="bibr">25</xref>. Another study in South Korea reported that 6.8% of total TB cases were MDR-TB, and 12.4% of these were XDR-TB<xref rid="B26" ref-type="bibr">26</xref>. In this study, six of the 36 patients (16.7%) diagnosed with TB were resistant to at least one anti-TB drug, and two (5.6%) had MDR-TB and it was consistent with previous study.</p><p>Host immunity against MTB declines with age<xref rid="B27" ref-type="bibr">27</xref>. We found that the number of TB cases per 10<sup>5</sup> of the population increased with age. A high prevalence of latent TB and TB re-activation may explain this finding. However, the high incidence of TB even in younger subjects suggests that TB remains infectious and is spreading among the young in South Korea. The incidence of TB in this study was 88.8 per 10<sup>5</sup> of the population, which is lower than the 89.6 per 10<sup>5</sup> of the population in the 2013 KTBS annual report of TB in Korea<xref rid="B28" ref-type="bibr">28</xref>. The incidence of TB among subjects 25&#x02013;34 years of age was greater in this work that in the 2013 report (113.78 vs. 76.4 per 10<sup>5</sup> of the population 25&#x02013;29 years of age and 60.4 per 10<sup>5</sup> of the population 30&#x02013;34 years of age, respectively). The difference between our findings and the KTBS report becomes greater with increasing age, with the exception of those 15&#x02013;24 years of age (19.3 vs. 37.2 per 10<sup>5</sup> of the population 15&#x02013;19 years of age and 62.7 per 10<sup>5</sup> of the population 20&#x02013;24 years of age, respectively).</p><p>Much effort has focused on controlling TB in South Korea. The latent TB infection (LTBI) guidelines are reinforced in the revision of the 2014 Korean guidelines for TB because LTBI treatment is important for reducing the incidence of TB<xref rid="B29" ref-type="bibr">29</xref>. Moreover, identification of active TB cases is also important for reducing the prevalence of TB.</p><p>This study had several limitations. First, it was performed in a single private hospital and was of a retrospective design, so the results are not representative of all visa applicants in South Korea. A multi-center prospective study would provide a clearer picture. Second, the study population consisted mostly of young subjects; less than 10% were over 35 years of age, possibly indicating selection bias. Third, AFB smear-positive and MTB culture-negative cases were common due to NTM or contamination of sputum. Fourth, most applicants refused to report their history of TB treatment to avoid further sputum tests; indeed, 14 applicants with CXR results suggestive of TB refused sputum tests. If these subjects had agreed to such testing, the TB frequency might have been higher.</p><p>The culture-based protocol identified a fivefold greater number of TB cases than the older smear-based protocol. TB screening tests, including consecutive sputum MTB culture tests, are essential for the diagnosis of, and epidemiological studies on, TB. The national TB control program needs to be enhanced, including by use of culture tests, if the prevalence of TB in South Korea is to be reduced.</p></sec></body><back><fn-group><fn fn-type="con"><p><bold>Authors' Contributions:</bold>
<list list-type="simple"><list-item><p><bold>Conceptualization:</bold> Lee S.</p></list-item><list-item><p><bold>Methodology:</bold> Lee S.</p></list-item><list-item><p><bold>Data curation:</bold> Ryu JY.</p></list-item><list-item><p><bold>Writing - original draft preparation:</bold> Lee S.</p></list-item><list-item><p><bold>Writing - review and editing:</bold> Kim DH.</p></list-item><list-item><p><bold>Approval of final manuscript:</bold> all authors.</p></list-item></list>
</p></fn><fn fn-type="COI-statement"><p><bold>Conflicts of Interest:</bold> No potential conflict of interest relevant to this article was reported.</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="book"><collab>World Health Organization</collab><source>Global tuberculosis report 2015. WHO/HTM/TB/2015.22 [Internet]</source><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><year>2015</year><date-in-citation content-type="access-date">cited 2017 Apr 1</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/tb/publications/global_report/en">http://www.who.int/tb/publications/global_report/en</ext-link></comment></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>YP</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Lew</surname><given-names>WJ</given-names></name><name><surname>Lee</surname><given-names>EK</given-names></name><name><surname>Han</surname><given-names>YC</given-names></name></person-group><article-title>The seventh nationwide tuberculosis prevalence survey in Korea, 1995</article-title><source>Int J Tuberc Lung Dis</source><year>1998</year><volume>2</volume><fpage>27</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">9562108</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>I</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Oh</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>JB</given-names></name><name><surname>Bai</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Diagnostic accuracy of notified cases as pulmonary tuberculosis in private sectors of Korea</article-title><source>J Korean Med Sci</source><year>2012</year><volume>27</volume><fpage>525</fpage><lpage>531</lpage><pub-id pub-id-type="pmid">22563218</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="book"><collab>Centers for Disease Control and Prevention</collab><source>Tuberculosis screening and treatment technical instructions (TB TIs) using cultures and directly observed therapy (DOT) for panel physicians [Internet]</source><publisher-loc>Atlanta</publisher-loc><publisher-name>Centers for Disease Control and Prevention</publisher-name><year>2013</year><date-in-citation content-type="access-date">cited 2017 Apr 1</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/immigrantrefugeehealth/exams/ti/panel/tuberculosis-panel-technical-instructions.html">https://www.cdc.gov/immigrantrefugeehealth/exams/ti/panel/tuberculosis-panel-technical-instructions.html</ext-link></comment></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><article-title>Diagnostic standards and classification of tuberculosis in adults and children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999</article-title><source>Am J Respir Crit Care Med</source><year>2000</year><volume>161</volume><issue>4 Pt 1</issue><fpage>1376</fpage><lpage>1395</lpage><pub-id pub-id-type="pmid">10764337</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JY</given-names></name></person-group><article-title>Tuberculosis infection control in health-care facilities: environmental control and personal protection</article-title><source>Tuberc Respir Dis (Seoul)</source><year>2016</year><volume>79</volume><fpage>234</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">27790274</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="book"><collab>World Health Organization</collab><source>Definitions and reporting framework for tuberculosis: 2013 revision [Internet]</source><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><year>2013</year><date-in-citation content-type="access-date">cited 2017 Apr 1</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf">http://apps.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf</ext-link></comment></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="book"><collab>Korea Centers for Disease Control and Prevention</collab><source>Annual report on the notified tuberculosis cases patients in Korea 2016</source><publisher-loc>Cheongju</publisher-loc><publisher-name>Korea Centers for Disease Control and Prevention</publisher-name><year>2017</year></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Painter</surname><given-names>JA</given-names></name><name><surname>Posey</surname><given-names>DL</given-names></name><name><surname>Cain</surname><given-names>KP</given-names></name><name><surname>Weinberg</surname><given-names>MS</given-names></name><name><surname>Maloney</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Estimating the impact of newly arrived foreignborn persons on tuberculosis in the United States</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><elocation-id>e32158</elocation-id><pub-id pub-id-type="pmid">22384165</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alami</surname><given-names>NN</given-names></name><name><surname>Yuen</surname><given-names>CM</given-names></name><name><surname>Miramontes</surname><given-names>R</given-names></name><name><surname>Pratt</surname><given-names>R</given-names></name><name><surname>Price</surname><given-names>SF</given-names></name><name><surname>Navin</surname><given-names>TR</given-names></name><etal/></person-group><article-title>Trends in tuberculosis: United States, 2013</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2014</year><volume>63</volume><fpage>229</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">24647398</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maloney</surname><given-names>SA</given-names></name><name><surname>Fielding</surname><given-names>KL</given-names></name><name><surname>Laserson</surname><given-names>KF</given-names></name><name><surname>Jones</surname><given-names>W</given-names></name><name><surname>Nguyen</surname><given-names>TN</given-names></name><name><surname>Dang</surname><given-names>QA</given-names></name><etal/></person-group><article-title>Assessing the performance of overseas tuberculosis screening programs: a study among US-bound immigrants in Vietnam</article-title><source>Arch Intern Med</source><year>2006</year><volume>166</volume><fpage>234</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">16432095</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Weinberg</surname><given-names>MS</given-names></name><name><surname>Ortega</surname><given-names>LS</given-names></name><name><surname>Painter</surname><given-names>JA</given-names></name><name><surname>Maloney</surname><given-names>SA</given-names></name></person-group><article-title>Overseas screening for tuberculosis in U.S.-bound immigrants and refugees</article-title><source>N Engl J Med</source><year>2009</year><volume>360</volume><fpage>2406</fpage><lpage>2415</lpage><pub-id pub-id-type="pmid">19494216</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behr</surname><given-names>MA</given-names></name><name><surname>Warren</surname><given-names>SA</given-names></name><name><surname>Salamon</surname><given-names>H</given-names></name><name><surname>Hopewell</surname><given-names>PC</given-names></name><name><surname>Ponce de Leon</surname><given-names>A</given-names></name><name><surname>Daley</surname><given-names>CL</given-names></name><etal/></person-group><article-title>Transmission of <italic>Mycobacterium tuberculosis</italic> from patients smear-negative for acid-fast bacilli</article-title><source>Lancet</source><year>1999</year><volume>353</volume><fpage>444</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">9989714</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewinsohn</surname><given-names>DM</given-names></name><name><surname>Leonard</surname><given-names>MK</given-names></name><name><surname>LoBue</surname><given-names>PA</given-names></name><name><surname>Cohn</surname><given-names>DL</given-names></name><name><surname>Daley</surname><given-names>CL</given-names></name><name><surname>Desmond</surname><given-names>E</given-names></name><etal/></person-group><article-title>Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children</article-title><source>Clin Infect Dis</source><year>2017</year><volume>64</volume><fpage>e1</fpage><lpage>e33</lpage><pub-id pub-id-type="pmid">27932390</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobby</surname><given-names>GL</given-names></name><name><surname>Holman</surname><given-names>AP</given-names></name><name><surname>Iseman</surname><given-names>MD</given-names></name><name><surname>Jones</surname><given-names>JM</given-names></name></person-group><article-title>Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis</article-title><source>Antimicrob Agents Chemother</source><year>1973</year><volume>4</volume><fpage>94</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">4208508</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeager</surname><given-names>H</given-names><suffix>Jr</suffix></name><name><surname>Lacy</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>LR</given-names></name><name><surname>LeMaistre</surname><given-names>CA</given-names></name></person-group><article-title>Quantitative studies of mycobacterial populations in sputum and saliva</article-title><source>Am Rev Respir Dis</source><year>1967</year><volume>95</volume><fpage>998</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">4961042</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>H</given-names></name><name><surname>Feldman</surname><given-names>C</given-names></name><name><surname>Sacho</surname><given-names>H</given-names></name><name><surname>van der Meulen</surname><given-names>H</given-names></name><name><surname>Kallenbach</surname><given-names>J</given-names></name><name><surname>Koornhof</surname><given-names>H</given-names></name></person-group><article-title>A reevaluation of sputum microscopy and culture in the diagnosis of pulmonary tuberculosis</article-title><source>Chest</source><year>1989</year><volume>95</volume><fpage>1193</fpage><lpage>1197</lpage><pub-id pub-id-type="pmid">2656111</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>MA</given-names></name><name><surname>Horstmeier</surname><given-names>CD</given-names></name><name><surname>DeYoung</surname><given-names>DR</given-names></name><name><surname>Roberts</surname><given-names>GD</given-names></name></person-group><article-title>Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens</article-title><source>J Clin Microbiol</source><year>1983</year><volume>18</volume><fpage>384</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">6194175</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichiyama</surname><given-names>S</given-names></name><name><surname>Shimokata</surname><given-names>K</given-names></name><name><surname>Takeuchi</surname><given-names>J</given-names></name></person-group><article-title>Comparative study of a biphasic culture system (Roche MB Check system) with a conventional egg medium for recovery of mycobacteria. Aichi Mycobacteriosis Research Group</article-title><source>Tuber Lung Dis</source><year>1993</year><volume>74</volume><fpage>338</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">8260667</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alausa</surname><given-names>KO</given-names></name><name><surname>Osoba</surname><given-names>AO</given-names></name><name><surname>Montefiore</surname><given-names>D</given-names></name><name><surname>Sogbetun</surname><given-names>OA</given-names></name></person-group><article-title>Laboratory diagnosis of tuberculosis in a developing country 1968-1975</article-title><source>Afr J Med Med Sci</source><year>1977</year><volume>6</volume><fpage>103</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">416665</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Posey</surname><given-names>DL</given-names></name><name><surname>Cetron</surname><given-names>MS</given-names></name><name><surname>Painter</surname><given-names>JA</given-names></name></person-group><article-title>Effect of a culturebased screening algorithm on tuberculosis incidence in immigrants and refugees bound for the United States: a population-based cross-sectional study</article-title><source>Ann Intern Med</source><year>2015</year><volume>162</volume><fpage>420</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">25775314</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posey</surname><given-names>DL</given-names></name><name><surname>Naughton</surname><given-names>MP</given-names></name><name><surname>Willacy</surname><given-names>EA</given-names></name><name><surname>Russell</surname><given-names>M</given-names></name><name><surname>Olson</surname><given-names>CK</given-names></name><name><surname>Godwin</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Implementation of new TB screening requirements for U.S.-bound immigrants and refugees, 2007-2014</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2014</year><volume>63</volume><fpage>234</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">24647399</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowenthal</surname><given-names>P</given-names></name><name><surname>Westenhouse</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>M</given-names></name><name><surname>Posey</surname><given-names>DL</given-names></name><name><surname>Watt</surname><given-names>JP</given-names></name><name><surname>Flood</surname><given-names>J</given-names></name></person-group><article-title>Reduced importation of tuberculosis after the implementation of an enhanced pre-immigration screening protocol</article-title><source>Int J Tuberc Lung Dis</source><year>2011</year><volume>15</volume><fpage>761</fpage><lpage>766</lpage><pub-id pub-id-type="pmid">21575295</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>GH</given-names></name><name><surname>Park</surname><given-names>YK</given-names></name><name><surname>Choi</surname><given-names>YW</given-names></name><name><surname>Bai</surname><given-names>JI</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Chang</surname><given-names>CL</given-names></name><etal/></person-group><article-title>Trend of anti-tuberculosis drug resistance in Korea, 1994-2004</article-title><source>Int J Tuberc Lung Dis</source><year>2007</year><volume>11</volume><fpage>571</fpage><lpage>576</lpage><pub-id pub-id-type="pmid">17439684</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>MY</given-names></name><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Lee</surname><given-names>YM</given-names></name><etal/></person-group><article-title>Drugresistance pattern of <italic>Mycobacterium tuberculosis</italic> strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center</article-title><source>Korean J Intern Med</source><year>2015</year><volume>30</volume><fpage>325</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">25995663</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mok</surname><given-names>JH</given-names></name><name><surname>Kang</surname><given-names>BH</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Jang</surname><given-names>HJ</given-names></name><name><surname>Cho</surname><given-names>YJ</given-names></name><etal/></person-group><article-title>Additional drug resistance patterns among multidrug-resistant tuberculosis patients in Korea: implications for regimen design</article-title><source>J Korean Med Sci</source><year>2017</year><volume>32</volume><fpage>636</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">28244290</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vesosky</surname><given-names>B</given-names></name><name><surname>Turner</surname><given-names>J</given-names></name></person-group><article-title>The influence of age on immunity to infection with <italic>Mycobacterium tuberculosis</italic></article-title><source>Immunol Rev</source><year>2005</year><volume>205</volume><fpage>229</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">15882357</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="book"><collab>Korea Center for Disease Control and Prevention</collab><source>Annual report on the notified tuberculosis patients in Korea, 2013</source><publisher-loc>Cheongju</publisher-loc><publisher-name>Korea Center for Disease Control and Prevention</publisher-name><year>2013</year></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SH</given-names></name></person-group><article-title>Diagnosis and treatment of latent tuberculosis infection</article-title><source>Tuberc Respir Dis</source><year>2015</year><volume>78</volume><fpage>56</fpage><lpage>63</lpage></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>The U.S. Centers for Disease Control and Prevention 1991 technical instructions for pre-immigration TB screening and treatment. Class A TB: active TB disease; Class B1 TB: chest radiographic data consistent with active TB; Class B2 TB: chest radiographic data consistent with inactive TB; TB: tuberculosis.</title></caption><graphic xlink:href="trd-82-151-g001"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>The complete Culture and Directly Observed Therapy Tuberculosis Technical Instructions of U.S. Centers for Disease Control and Prevention. Class A TB: active TB disease; Class B1 TB: chest radiographic data consistent with active TB; TB: tuberculosis; HIV: human immunodeficiency virus; DOT: directly observed therapy.</title></caption><graphic xlink:href="trd-82-151-g002"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>General characteristics of the study population (n=40,558)</title></caption><alternatives><graphic xlink:href="trd-82-151-i001"/><table frame="hsides" rules="rows"><col width="49.26%" span="1"/><col width="50.74%" span="1"/><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">Characteristic</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">No. (%)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Sex</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;Male</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">22,718 (56.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Female</td><td valign="top" align="center" rowspan="1" colspan="1">17,840 (44.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">Visiting country</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;United States</td><td valign="top" align="center" rowspan="1" colspan="1">1,406 (3.5)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;Canada</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">10,691 (26.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Australia</td><td valign="top" align="center" rowspan="1" colspan="1">28,461 (70.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">Age, mean&#x000b1;SD (yr)</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">26.8&#x000b1;6.6</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;15&#x02013;24</td><td valign="top" align="center" rowspan="1" colspan="1">15,532 (38.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;25&#x02013;34</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">21,980 (54.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;35&#x02013;44</td><td valign="top" align="center" rowspan="1" colspan="1">1,855 (4.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;45&#x02013;54</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">739 (1.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;55&#x02013;64</td><td valign="top" align="center" rowspan="1" colspan="1">281 (0.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;&#x02265;65</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">171 (0.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Previous treatment history of TB</td><td valign="top" align="center" rowspan="1" colspan="1">31 (0.1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">Suggestive of TB on CXR</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">365 (0.9)</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>TB: tuberculosis; CXR: chest X-ray.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Sputum test results of those with abnormal chest radiographs (n=351)</title></caption><alternatives><graphic xlink:href="trd-82-151-i002"/><table frame="hsides" rules="rows"><col width="49.26%" span="1"/><col width="50.74%" span="1"/><thead><tr><th valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">Variable</th><th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">No. (%)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">AFB smear and MTB culture</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;AFB smear (&#x02212;) and MTB culture (&#x02212;)</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">315 (89.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;AFB smear (+) and MTB culture (&#x02212;)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (0.9)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;AFB smear (&#x02212;) and MTB culture (+)</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">29 (8.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;AFB smear (+) and MTB culture (+)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (1.1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">No. of positive AFB smears</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">7 (2.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;One</td><td valign="top" align="center" rowspan="1" colspan="1">5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;Two</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Three</td><td valign="top" align="center" rowspan="1" colspan="1">2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">No. of positive MTB cultures</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">33 (9.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;One</td><td valign="top" align="center" rowspan="1" colspan="1">11</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;Two</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">17</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Three</td><td valign="top" align="center" rowspan="1" colspan="1">5</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>AFB: acid-fast bacilli; MTB: <italic>Mycobacterium tuberculosis</italic>.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Characteristics of the TB cases identified using different technical instructions</title></caption><alternatives><graphic xlink:href="trd-82-151-i003"/><table frame="hsides" rules="rows"><col width="25%" span="1"/><col width="11.71%" span="1"/><col width="18.35%" span="1"/><col width="13.29%" span="1"/><col width="18.35%" span="1"/><col width="13.29%" span="1"/><thead><tr><th valign="middle" align="left" rowspan="2" colspan="1" style="background-color:rgb(215,217,218)">Characteristic</th><th valign="middle" align="center" rowspan="1" colspan="2" style="background-color:rgb(215,217,218)">1991 TI</th><th valign="middle" align="center" rowspan="1" colspan="2" style="background-color:rgb(215,217,218)">2007 TI using CDOT</th><th valign="middle" align="center" rowspan="2" colspan="1" style="background-color:rgb(215,217,218)">p-value</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">No. (%)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">Cases per 10<sup>5</sup> of the population</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">No. (%)</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">Cases per 10<sup>5</sup> of the population</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">TB cases identified</td><td valign="top" align="center" rowspan="1" colspan="1">7 (17.3)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">36 (88.8)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">Sex</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)"/><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)"/><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)"/><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)"/><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Male</td><td valign="top" align="center" rowspan="1" colspan="1">4 (57.1)</td><td valign="top" align="center" rowspan="1" colspan="1">17.6</td><td valign="top" align="center" rowspan="1" colspan="1">22 (61.1)</td><td valign="top" align="center" rowspan="1" colspan="1">96.8</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;Female</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">3 (42.9)</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">16.8</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">14 (38.9)</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">78.5</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">0.007</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, yr</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;15&#x02013;24</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">-</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">-</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">3 (8.3)</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">19.3</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">0.250</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;25&#x02013;34</td><td valign="top" align="center" rowspan="1" colspan="1">5 (71.4)</td><td valign="top" align="center" rowspan="1" colspan="1">22.7</td><td valign="top" align="center" rowspan="1" colspan="1">25 (69.4)</td><td valign="top" align="center" rowspan="1" colspan="1">113.7</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;35&#x02013;44</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">-</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">-</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">3 (8.3)</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">161.7</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">0.499</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;45&#x02013;54</td><td valign="top" align="center" rowspan="1" colspan="1">1 (14.3)</td><td valign="top" align="center" rowspan="1" colspan="1">135.3</td><td valign="top" align="center" rowspan="1" colspan="1">3 (8.3)</td><td valign="top" align="center" rowspan="1" colspan="1">406.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.624</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;55&#x02013;64</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">-</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">-</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">1 (2.8)</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">355.9</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x0003e;0.999</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02265;65</td><td valign="top" align="center" rowspan="1" colspan="1">1 (14.3)</td><td valign="top" align="center" rowspan="1" colspan="1">584.8</td><td valign="top" align="center" rowspan="1" colspan="1">1 (2.8)</td><td valign="top" align="center" rowspan="1" colspan="1">584.8</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;0.999</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">Drug-resistant TB</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)"/><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)"/><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">6 (16.7)<sup>*</sup></td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)"/><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;MDR-TB</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">2 (5.6)<sup>*</sup></td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">&#x02003;XDR-TB</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">-</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">-</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">0 (0)</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">-</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(215,217,218)">-</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p><sup>*</sup>Percentage of TB cases.</p><p>TB: tuberculosis; TI: technical instruction; CDOT: culture and directly observed therapy; MDR: multidrug-resistant; XDR: extensively drugresistant.</p></fn></table-wrap-foot></table-wrap></floats-group></article>